Background. Among adolescents and young adults with DSM-IV alcohol use disorders (AUDs), there are interindividual differences in the speed of transition from initial alcohol use (AU) to AUD. AUDs are highly co-morbid with other mental disorders. The factors associated with rapid transition from first AU to AUD remain unknown and the role of mental disorders in rapid transitions is unclear. Given this background we examined (1) whether prior anxiety, mood, externalizing and non-alcohol substance use disorders are related to the risk and speed of transition from first AU to DSM-IV alcohol abuse (AA) and alcohol dependence (AD) and (2) whether early age of onset of prior mental disorders (PMDs) is a promoter of rapid transition.
Introduction
In this study we investigated whether DSM-IV anxiety, mood, non-alcohol substance use disorders (DSM-IV abuse and dependence) and externalizing disorders that occur prior to DSM-IV alcohol use disorders (AUDs) are associated with an increased risk and speed of transition from first alcohol use (AU) to DSM-IV alcohol abuse (AA) and alcohol dependence (AD) in adolescence and young adulthood. In this regard, we also examined the role of early onset of prior mental disorders (PMDs) and gender.
AU is associated with the risk of serious consequences such as cardiovascular disease, unintentional injuries (Rehm et al. 2006) and AUDs. AUDs (especially AD) are disabling mental disorders (Hasin et al. 2007 ) and may occur as early as in adolescence and young adulthood (Bonomo et al. 2004 ; Grant et al. 2004a ; Nelson & Wittchen, 1998) . AD with onset in adolescence is especially malignant (Hingson et al. 2006) . AUDs are highly co-morbid with mood, anxiety, externalizing and other substance use disorders. Co-morbidity is more frequent in younger adults (Burns & Teesson, 2002 ; Kendler et al. 2003 ; Grant et al. 2004b ; Hasin et al. 2007) .
Mental disorders and their symptoms are risk factors for AUDs and problematic AU (Kushner et al. 1999 ; Crum & Pratt, 2001 ; Zimmermann et al. 2003 ; Goodwin et al. 2004 ; Haynes et al. 2005) . For example, social phobia and pronounced depressive symptoms predicted AD (Gilman & Abraham, 2001 ; Crum et al. 2008a ; Buckner & Turner, 2009) . Externalizing disorders are well-documented risk factors for AUDs (Elkins et al. 2007) . However, few studies on this topic fulfill all of the following criteria : inclusion of young adolescents, a long follow-up interval and a wide range of DSM-IV diagnoses considered as predictors and control variables (Buckner et al. 2008a) . Therefore, we investigate various DSM-IV PMDs as risk factors for DSM-IV AUDs with thorough adjustment for covariates in a 10-year prospective epidemiological study including young adolescents.
We hypothesized that an excess risk of AUD exists for especially early PMD onset. Earlier PMDs show greater severity and co-morbidity, poorer health outcomes and problematic coping styles (Beesdo et al. 2007 ; Keenan-Miller et al. 2007 ; Hammen et al. 2008 ; Sansone & Sansone, 2009 ). Early-onset PMDs predict problematic substance use behaviors that are related to AUDs (DeWit et al. 2000 ; Bonomo et al. 2004 ; Crum et al. 2008b ; Sihvola et al. 2008) . Major depression and social phobia also occurred earlier in subjects with secondary AUD than in subjects without AUD (Grant et al. 1996 ; Buckner et al. 2008b) .
It is also of interest to determine whether PMDs play a role in the speed of transition to AUDs. The substance-specific latency between first use and onset of a substance use disorder is longer for alcohol than for cannabis and cocaine (Wagner & Anthony, 2002 ; Behrendt et al. 2009 ). It can span more than 10 years (DeWit et al. 2000) with considerable inter-individual variation. Some adolescents develop an AUD in the first 2 years after first AU (Wittchen et al. 2008) . Information on the promoters of such rapid transitions would improve the understanding of individual differences in AUD development and help to identify subjects who need timely interventions (Wittchen et al. 2008) and have poorer AD prognoses (Hingson et al. 2006) . However, factors characterizing these subjects remain understudied. Because of lower self-efficacy (John et al. 2004 ), higher impulsivity (Kliegel et al. 2006) , and instrumental AU (Thomas et al. 2003) in mental disorders, PMDs may lead to reduced control over AU. Therefore, we hypothesized that any and early PMDs are associated with faster transitions to AUDs.
Although gender differences in AUDs (Grant et al. 2004a) , mood, anxiety and externalizing disorders (Blazer et al. 1994 ; Wittchen et al. 1998b ; Kendler et al. 2003 ; Wilhelm et al. 2003) are well documented, the role of gender in the relationship between PMD and the speed of transition to AUD remains unclear. Female gender has been linked with faster transitions to alcohol problems (Randall et al. 1999) , but more recent studies found no or little evidence for a faster AUD development in women (Wagner & Anthony, 2007 ; Wittchen et al. 2008) . We hypothesized that there are no gender differences in the speed of transition to AUD.
Given this background we examined whether (1) PMDs are associated with a higher risk of AUDs and a higher speed of transition from first AU to AUD, (2) associations with speed of transition differ by gender and (3) early PMD onset is associated with the risk and speed of transition.
Method

Study sample and design
The Early Developmental Stages of Psychopathology (EDSP) study is a prospective longitudinal community study on the prevalence, course, vulnerabilities and risk factors of substance use and substance use disorders in adolescence and early adulthood. The study includes a baseline (T0 ; conducted in 1995) and three follow-up assessments (T1, T2, T3) (Wittchen et al. 1998c ; Lieb et al. 2000 ; Beesdo et al. 2010) .
The study sample consisted of 3021 Germanspeaking subjects (1533 males, 1488 females) aged 14-24 years at baseline. The sample was drawn randomly from government registries in metropolitan Munich, Germany. As the study focused on early developmental stages of psychopathology, individuals aged 14-15 years were sampled at twice the probability of those aged 16-21 years, who were sampled at twice the probability of those aged 22-24 years. The followup examinations were carried out approximately 1.6 years (T1, median interval since baseline), 3.5 years (T2) and 8.2 years (T3) later. At T1, only the younger cohort of subjects aged 14-17 years at baseline was assessed (n=1228). Response rates were 70.9 % at T0 (n=3021), 84.3 % (n=2548) at T2 and 73.2 % (n=2210) at T3. At T3, the age range was 21-34 years. Further detailed information on the study can be found elsewhere (Wittchen et al. 1998c ; Lieb et al. 2000) .
Participants were asked whether they were willing to answer questions on illegal substances truthfully (commitment probe). A total of 142 subjects who declined at one or more waves were excluded from all analyses with variables concerning illegal substances.
Any AU, regular AU (at least weekly) or hazardous AU (o20 g of ethanol for women or o40 g of ethanol for men almost every day) at T0 did not predict dropout at any follow-up, with one exception : in the younger cohort, regular AU at T0 predicted drop-out at the first but not at any other follow-up (if subjects did not participate in T1, the T0-T2 interval was covered in the T2 assessment).
The cumulative incidence rate up to T3 was 97.7 % for AU (n=2929), 24.7 % for AA (n=741) and 11.0 % for AD (n=327).
Diagnostic assessment
At all assessment waves, participants were interviewed face to face with the computer-assisted, fully standardized Munich-Composite International Diagnostic Interview (DIA-X/M-CIDI ; Wittchen & Pfister, 1997 ; Wittchen et al. 1998a) , an updated version of the World Health Organization (WHO) CIDI (Wittchen & Semmler, 1990) . The lifetime version was used at baseline ; a follow-up interval version was used at the subsequent waves. With the DIA-X/M-CIDI it is possible to assess symptoms, syndromes and diagnoses of 48 mental disorders, along with information about onset, severity and impairment. For the diagnoses presented here, the computerized M-CIDI/ DSM-IV algorithms were applied. The DIA-X/M-CIDI is supplemented by a respondent's booklet including symptom lists and cognitive aids to help the respondent with answering symptom questions. The testretest reliability and validity of the DIA-X/M-CIDI diagnoses have been established (Lachner et al. 1998 ; Reed et al. 1998 ; Wittchen et al. 1998a) . Interviewers, most of whom were clinical psychologists, received intensive training on the DIA-X/M-CIDI, followed by monitored practice interviews at baseline and booster sessions before each subsequent wave. Further information has been provided elsewhere (Wittchen et al. 1998c ; Lieb et al. 2000) .
Assessment of AU and AUD
AU and AUD were assessed with the DIA-X/M-CIDI section on AU, which begins with questions on quantity, frequency, age of onset and age of recency of use. For the assessment of diagnostic criteria, at least minimal AU was required ; defined as (1) AU at least three times a week, or more than three ' standard drinks ' per drinking day, in subjects who had drunk on more than 12 occasions in at least 1 year of their lives (applied for AD) or (2) AU on at least 13 occasions in a 12-month period (for AA). AD was also assessed in subjects who met the minimal AU criteria in shorter periods. The following AU levels were considered here : any use, DSM-IV dependence and DSM-IV abuse (non-hierarchical).
Statistical analysis
To account for different sampling probabilities at baseline according to age, and response rates at baseline varying over age, gender and geographic region, data were weighted. The Stata Software package version 11.0 (StataCorp, 2009) was used for all calculations and to compute robust variances, confidence intervals (CIs) and p values (by applying the HuberWhite sandwich matrix) required when basing analyses on weighted data (Royall, 1986) . Cumulative lifetime incidence was generated using the last observation carried forward (LOCF) method, that is the information obtained until the last available assessment was taken into account. This enabled us to use information from subjects who had dropped out of the study during the assessments. According to CIDI conventions, age of AUD onset was defined as age at first AUD symptom.
The Kaplan-Meier (Therneau & Grambsch, 2000) estimator was used to estimate the age-dependent cumulative lifetime incidence of AU and mental disorders. Cox regressions were applied for assessing overall differences in risk of transition from first AU to AUD over time (time scale=years from first AU to AUD) across PMD status. Covariates (factors of interest and control variables) were entered into the Cox regression analysis as time-dependent covariates to ensure that PMD had occurred prior to AUD [age of onset of PMD <t, t=1, 2, …, minimum (age of onset AUD -age of onset AU, age at last assessment -age of onset AU)]. In the Cox regression, cases with AU and AUD onset within the same 12-month period (i.e. length of transition=0 years) are excluded automatically in Stata (StataCorp, 2009) . To prevent this, we shifted the time scale by 1 year upwards, by replacing 0 years by 1 year, 1 year by 2 years, and so on.
Different curves according to birth cohort and gender were allowed for by fitting stratified Cox regressions (Therneau & Grambsch, 2000) . Schoenfeld residuals were used to test whether group differences varied over time (Therneau & Grambsch, 2000) . When necessary, the interaction term covariaternumber of years since AU was added to the model, to improve the model fit and to assess how strongly the hazard ratios (HRs) varied over time. Here, the model-based time-dependent HR is given by : HR(t)=HR (main effect of covariate)rHR (interaction effect of covariate) t , where t is the number of years since onset of AU.
For the Cox regression analysis, we used data from subjects with lifetime AU (n=2929). Few subjects had reported AU, AUD or mental disorders other than AUD, but had not provided the respective age of onset information. Data from these subjects were excluded from the survival analyses 1 .# To assess whether early PMD onset was associated with a higher speed of transition to AUD we used the dimensional age of onset of the respective PMD, that is we determined whether higher (compared to lower) age of onset was associated with the speed of transition. Subjects with PMD onset after or in the same year as AUD onset were excluded from this analysis. First, the Cox regression analysis was conducted with adjustment for age and gender (model I). In model II, we additionally adjusted for other PMDs : if the covariate of interest was a mood disorder, we adjusted for any anxiety disorder and non-alcohol substance use disorders (nicotine dependence, cannabis abuse or dependence, abuse or dependence of illegal drugs other than cannabis). If the covariate of interest was an anxiety disorder, we adjusted for any mood disorder and non-alcohol substance use disorders. When the covariate of interest was a non-alcohol substance use disorder, we adjusted for all other nonalcohol substance use disorders, any anxiety and any mood disorder. With externalizing disorders as covariate, we adjusted for any mood, any anxiety and all non-alcohol substance use disorders. For anxiety disorders that were significant predictors in model II, we repeated model II with additional adjustment (model IIA) for selected other anxiety disorders (other anxiety disorders were selected as covariates only if they were significant predictors in model II) and for a category of those anxiety disorders that are otherwise not considered as covariates here because of insufficient power (see next section). In model III, we repeated model II with additional adjustment for externalizing disorders. Statistical power did not permit differentiation between substance use disorders related to illegal drugs other than cannabis.
Covariates
Covariates (PMDs) were calculated from their cumulative lifetime status and the respective age of onset variable for : any mood, any anxiety and any nonalcohol substance use disorder 2 , major depression, dysthymia, bipolar disorder (bipolar I and bipolar II disorder), specific phobia, social phobia, nicotine dependence, cannabis abuse (non-hierarchical) and somatoform disorders (any DSM-IV somatoform disorder or somatoform/dissociative syndrome including SSI 4/6). For phobias, impairment was assessed but only requested for DSM-IV diagnosis after age 17 because of the possibly limited reliability of impairment reports in young respondents and because these disorders occur particularly early (Wittchen et al. 1999a, b) . DSM-IV panic attacks were considered and are subsequently listed among the anxiety disorders but not included in the any anxiety disorder variable. Diagnosis of externalizing disorders (conduct or antisocial personality disorder) was obtained from parental reports on conduct disorder at T1 and participants ' reports on both disorders at T2 resulting in information on 2638 subjects. Age of onset of antisocial personality disorder was set to age 13 by convention 3 .
Results
Co-morbidity and temporal sequence Table 1 shows that rates of lifetime AU in subjects with lifetime mental disorders were comparable to those in the entire sample. The risk of lifetime AUD was elevated for all considered lifetime disorders (all p values <0.05). In the case of lifetime co-morbidity, onset of specific mental disorders occurred prior to AU in over 50 % of subjects with specific phobia, social phobia and externalizing disorders, but secondary to AU for 64.5-96.5 % of cases of all other mental disorders except somatoform disorders. Other mental disorders mainly occurred primary to AA (except major depression, dysthymia, panic attacks and substance use disorders) and to AD (except substance use disorders, major depression and panic attacks).
PMD and the risk and speed of transition to AUD
Model I : adjusted for age and gender. Table 2 shows that all mood and anxiety disorders, cannabis abuse, nicotine dependence, somatoform and externalizing disorders were associated with a higher risk for AA and (Table 1 footnote continued) e Hierarchy rule not applied. f Number of co-morbid cases ; only cases who provided age of onset information were considered. g Total number of cases with the respective diagnosis in the sample (irrespective of alcohol use or alcohol use disorder). h Either conduct disorder or antisocial personality disorder ; based on information from 2638 subjects at T1 and T2. i Any anxiety disorder : panic disorder, agoraphobia without history of panic disorder, generalized anxiety disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), specific and social phobia ; any mood disorder : major depression, dysthymia, bipolar disorder I or II ; any non-alcohol substance use disorder : nicotine dependence or any illegal substance use disorder. * Higher risk of lifetime alcohol abuse or dependence (odds ratio adjusted for gender and age at last observation significant with p<0.05 ; table with odds ratios and 95 % confidence intervals available upon request). (nicotine dependence, cannabis abuse or dependence, abuse or dependence of illegal drugs other than cannabis), any anxiety disorder (not if the covariate of interest was an anxiety disorder), and any mood disorder (not if the covariate of interest was a mood disorder). When the covariate of interest was a substance use disorder, the specific analysis was not adjusted for this AD (comparison group in models I-III were subjects without the respective PMD). Two significant interactions with time (not shown in Table 2 ) were found : social phobia was associated with a lower speed of transition to AD (main effect HR 1.19, interaction effect HR 1.14, 95 % CI 1.02-1.27, p=0.019). Externalizing disorders were associated with a higher speed of transition to AD (main effect HR 4.69, interaction effect HR 0.89, 95 % CI 0.82-0.98, p=0.018).
Model II : additional adjustment for other PMD. Bipolar disorder, social phobia, panic attacks, nicotine dependence, cannabis abuse and externalizing disorders were associated with a higher risk of AA. AD was predicted by bipolar disorder, specific phobia, social phobia, panic attacks, nicotine dependence and externalizing disorders. Surprisingly, in model II, social phobia was associated with a higher speed of transition to AD (main effect HR 0.95, interaction effect HR 1.12, 95 % CI 1.008-1.26, p=0.035), as were externalizing disorders (main effect HR 3.25, interaction effect HR 0.90, 95 % CI 0.83-0.98, p=0.027).
Model IIA : adjustment for selected anxiety disorders. In this model, all associations were adjusted for rare anxiety disorders and for those particular anxiety disorders that were significant predictors in model II. Social phobia did not predict AA (additional covariate : panic attacks). Panic attacks did not predict AA (additional covariate : social phobia). Specific phobia predicted AD (additional covariates : social phobia, panic attacks). Social phobia was not associated with the risk but with a higher speed of transition to AD (main effect HR 0.79, interaction effect HR 1.12, 95 % CI 1.002-1.26, p=0.045 ; additional covariates : specific phobia, panic attacks). Panic attacks did not predict AD (additional covariates : specific and social phobia).
Model III : additional adjustment for externalizing disorders. In this model, bipolar disorder, cannabis abuse and nicotine dependence were associated with a higher risk of AA. AD was predicted by bipolar disorder, specific phobia and nicotine dependence. Social phobia was associated with a higher speed of transition to AD (main effect HR 0.69, interaction effect HR 1.14, 95 % CI 1.009-1.30, p=0.036).
Gender differences
To assess whether associations between PMD and the speed of transition to AUD differed by gender, we added the interaction term PMDrgenderrtime to the model. The only significant interaction was found for dysthymiargenderrtime (AA as outcome, p=0.015).
In the male and female subgroups, the results on the association between dysthymiartime and AA indicated a trend towards a faster transition to AA in women with dysthymia (main effect HR 2.19, interaction effect HR 0.84, 95 % CI 0.70-1.02, p=0.093) and a trend towards a slower transition to AA in men (main effect HR 1.91, interaction effect HR 1.05, 95 % CI 0.92-1.18, p=0.424), but the results were not significant.
Earlier PMD onset
Earlier age of onset of major depression, dysthymia, specific phobia and cannabis abuse was associated with a higher risk of AA. In model II, this was found for major depression and cannabis abuse. Table 3 shows that earlier onset of major depression, specific phobia and nicotine dependence was associated with a higher risk of AD in both models. In model I, later age of onset of panic attacks was marginally associated with a faster transition to AA (main effect HR 0.73, interaction effect HR 1.07, 95 % CI 1.01-1.13, p=0.011) and AD (main effect HR 0.63, particular, but for all other substance use disorders. When the covariate of interest was an externalizing disorder, the analysis was adjusted for any mood, any anxiety and all non-alcohol substance use disorders. Model IIA : as model II but with additional adjustment for anxiety disorders that predicted the respective alcohol use disorder (AUD) in model II and for an aggregated variable including generalized anxiety disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), agoraphobia without history of panic disorder and panic disorder. gender differences in the speed of transition to AD (Wagner & Anthony, 2007 ; Wittchen et al. 2008) . Nicotine dependence and cannabis use disorders were not associated with more rapid transitions to AUD, possibly because their main incidence phases overlap with those of AUD (Wittchen et al. 2008) . These disorders may be proximal predictors that occur towards the end of the transition to AUD. Subjects with mood disorders may not experience the shortlived alcohol effects as a significant contribution to symptom relief, which may prevent a fast development of instrumental drinking.
Early age of onset of PMD was associated with a higher risk but not a higher speed of transition to AUD. An excess risk of AUD was found for early onset of nicotine dependence, specific phobia and cannabis abuse. In contrast to major depression per se, early major depression was associated with the risk of AUD independent of anxiety disorders. Thus, early psychopathology may be a relevant distal risk factor for AUD and warrants attention in the prevention of AUD in adolescence/early adulthood. Our results add to the finding that problem behaviors in childhood and adolescence predict AU-related problems in adulthood (Pitkänen et al. 2008) . The links between early psychopathology and AUD remain to be identified. The stability of psychopathology into adolescence may play a role here (Dubow et al. 2008 ; Hayatbakhsh et al. 2008) .
Limitations
We could not consider all PMDs of interest because of insufficient statistical power. The study covers the high-risk phase of AUD in adolescence/early adulthood but does not permit conclusions concerning AUD onset in middle/late adulthood. We used retrospective age-of-onset information that may underlie recall bias.
Future research should identify factors associated with rapid transitions to AUD and the mechanisms linking early psychopathology with AUD. Here, investigating the role of parental AU and AUD would be of interest. It would be important to investigate which characteristics of PMDs as certain symptoms or subtypes (as of specific phobia) are related to AUDs. We used non-hierarchical AA diagnosis in order to take into account all AUDs that occurred over the observed period. In future research it may be of interest to investigate cases that develop AA only.
In summary, we could show that PMDs are rarely associated with rapid transitions to AUDs in adolescence and early adulthood. However, different PMDs play an important role as risk factors for AUDs in this period.
2 Any anxiety disorder : panic disorder, agoraphobia without history of panic disorder, generalized anxiety disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), specific and social phobia ; any mood disorder : major depression, dysthymia, bipolar disorder I or II ; any non-alcohol substance use disorder : nicotine dependence or any illegal substance use disorder. 3 Because of insufficient statistical power, the analysis could not be conducted for panic disorder, generalized anxiety disorder, agoraphobia without history of panic disorder, OCD, PTSD and cannabis dependence.
